Drug Type Small molecule drug |
Synonyms 4-Pivalamidobutyric acid, Pivagabine (INN) + [1] |
Target |
Action antagonists |
Mechanism CRHR1 antagonists(Corticotropin-releasing factor receptor 1 antagonists), CRHR2 antagonists(Corticotropin-releasing factor receptor 2 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC9H17NO3 |
InChIKeySRPNQDXRVRCTNK-UHFFFAOYSA-N |
CAS Registry69542-93-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D07342 | Pivagabine |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anxiety Disorders | Phase 2 | - | - | |
Anxiety Disorders | Phase 2 | United States | - | |
Depressive Disorder | Phase 2 | United States | - | |
Stress, Psychological | Phase 2 | United States | - |